Immunosuppression for liver transplantation in HCV-infected patients: mechanism-based principles.
about
Importance of liver biopsy findings in immunosuppression management: biopsy monitoring and working criteria for patients with operational toleranceThe unfinished legacy of liver transplantation: emphasis on immunology.Themes of liver transplantation.Acquired immunologic tolerance: with particular reference to transplantationKidney after nonrenal transplantation-the impact of alemtuzumab induction.The influence of induction therapy for kidney transplantation after a non-renal transplant.Effect of nonviral factors on hepatitis C recurrence after liver transplantation.Long-term management of immunosuppression after pediatric liver transplantation: is minimization or withdrawal desirable or possible or both?Hepatitis C in Liver Allograft Recipients: Utility of One-Year Post-Transplantation Biopsy as an Indicator of Antiviral TherapyEffect of maintenance immunosuppressive drugs on virus pathobiology: evidence and potential mechanisms.Kidney after Extrarenal Transplantation - The Impact of Alemtuzumab InductionThe interrelation between recurrent hepatitis C, alloimmune response, and immunosuppression.Impact of steroids on hepatitis C virus replication in vivo and in vitro.Early extensive viremia, but not rs8099917 genotype, is the only predictor for cholestatic hepatitis C after living-donor liver transplantation.Completely steroid-free immunosuppression in liver transplantation: a randomized study.Immunosuppression induction with rabbit anti-thymocyte globulin with or without rituximab in 1000 liver transplant patients with long-term follow-up.
P2860
Q27026283-C4E2724A-E81C-47EA-8E82-541BEDC6D237Q30352760-DAAE46FE-E0BB-47AC-827C-BE6E03ADE3ACQ30658256-6340C183-D9B7-481B-BE41-C303867E799FQ33567138-52A36FA2-94BF-4537-B4A4-BCD0C8646A44Q34546898-AF50AC0A-08E5-409F-926E-83F24761B884Q35692427-31B34FC7-4A45-4454-B5F7-2D1265D354E1Q36602497-9A36947D-9FFA-4A02-B8AD-DD9BF8E8D48FQ37307173-E5A9A4FD-70BF-4B48-8102-40BD37888158Q37311439-913E1DFA-9DE7-4F8D-BF00-280157E899E8Q38061056-A4C92EC4-D5ED-4B1F-AA8E-6B4D3F0F623CQ41161206-AD0AE553-3C75-43B0-A379-639FDED24A5AQ42996064-E7814D2F-1083-4238-93B1-1731F3BC0958Q43041106-ACD1D40E-5FB8-4919-80C6-A51019C1B432Q45722353-BDB91D79-8E40-453B-BAC9-DD612A57BBA4Q45765341-FBD01321-BA89-4263-9DCC-0A67651ED8F7Q46366270-CFF81640-4802-4FD3-9973-C9462984106B
P2860
Immunosuppression for liver transplantation in HCV-infected patients: mechanism-based principles.
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Immunosuppression for liver tr ...... s: mechanism-based principles.
@ast
Immunosuppression for liver tr ...... s: mechanism-based principles.
@en
Immunosuppression for liver tr ...... s: mechanism-based principles.
@nl
type
label
Immunosuppression for liver tr ...... s: mechanism-based principles.
@ast
Immunosuppression for liver tr ...... s: mechanism-based principles.
@en
Immunosuppression for liver tr ...... s: mechanism-based principles.
@nl
prefLabel
Immunosuppression for liver tr ...... s: mechanism-based principles.
@ast
Immunosuppression for liver tr ...... s: mechanism-based principles.
@en
Immunosuppression for liver tr ...... s: mechanism-based principles.
@nl
P2093
P2860
P50
P356
P1476
Immunosuppression for liver tr ...... s: mechanism-based principles.
@en
P2093
Amadeo Marcos
Bridget Flynn
Debra C Bass
Edward A Gray
Noriko Murase
Obaid Shakil
Roberta Ness
P2860
P304
P356
10.1002/LT.20536
P577
2005-11-01T00:00:00Z